Neurologic Adverse Effects of Ranolazine in an Elderly Patient with Renal Impairment.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. e9, doi. 10.1002/phar.1152
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2013 AND VI 33 AND IP 1
Results: 16
1
2
Ruxolitinib: A New Treatment Option for Myelofibrosis.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 84, doi. 10.1002/phar.1165
- By:
- Publication type:
- Article
3
Therapeutic Effect of Conivaptan Bolus Dosing in Hyponatremic Neurosurgical Patients.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 51, doi. 10.1002/phar.1169
- By:
- Publication type:
- Article
4
Celebrating 32 Years of Pharmacotherapy.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 1, doi. 10.1002/phar.1245
- By:
- Publication type:
- Article
5
Prevalence of and Factors That Influence Board Certification Among Pharmacy Practice Faculty at United States Colleges and Schools of Pharmacy.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 105, doi. 10.1002/phar.1171
- By:
- Publication type:
- Article
6
Acceptance of Recommendations by Inpatient Pharmacy Case Managers: Unintended Consequences of Hospitalist and Specialist Care.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 11, doi. 10.1002/phar.1164
- By:
- Publication type:
- Article
7
Analysis of Benzonatate Overdoses Among Adults and Children from 1969-2010 by the United States Food and Drug Administration.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 38, doi. 10.1002/phar.1153
- By:
- Publication type:
- Article
8
Evaluation of Dosing and Clinical Outcomes in Patients Undergoing Conversion of Insulin Glargine to Insulin Detemir.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 56, doi. 10.1002/phar.1168
- By:
- Publication type:
- Article
9
Brentuximab Vedotin: A CD30-Directed Antibody-Cytotoxic Drug Conjugate.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 93, doi. 10.1002/phar.1170
- By:
- Publication type:
- Article
10
Ambulatory Blood Pressure Monitoring: Recent Evidence and Clinical Pharmacy Applications.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 69, doi. 10.1002/phar.1167
- By:
- Publication type:
- Article
11
Voriconazole Serum Concentrations in Obese and Overweight Immunocompromised Patients: A Retrospective Review.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 22, doi. 10.1002/phar.1156
- By:
- Publication type:
- Article
12
Sublingual Tacrolimus: A Pharmacokinetic Evaluation Pilot Study.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 31, doi. 10.1002/phar.1149
- By:
- Publication type:
- Article
13
Randomized Response Estimates for the 12-Month Prevalence of Cognitive-Enhancing Drug Use in University Students.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 44, doi. 10.1002/phar.1166
- By:
- Publication type:
- Article
14
Tigecycline-Related Pancreatitis: A Review of Spontaneous Adverse Event Reports.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 63, doi. 10.1002/phar.1159
- By:
- Publication type:
- Article
15
Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 3, doi. 10.1002/phar.1220
- By:
- Publication type:
- Article
16
Posaconazole Pharmacokinetics in a 2-Year-Old Boy with Rhino-Cerebral-Orbital Zygomycosis.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. e1, doi. 10.1002/phar.1172
- By:
- Publication type:
- Article